[go: up one dir, main page]

MX2008000780A - Combinacion terapeutica que comprende un bloqueador de receptores nmda y una sustancia narcotica analgesica. - Google Patents

Combinacion terapeutica que comprende un bloqueador de receptores nmda y una sustancia narcotica analgesica.

Info

Publication number
MX2008000780A
MX2008000780A MX2008000780A MX2008000780A MX2008000780A MX 2008000780 A MX2008000780 A MX 2008000780A MX 2008000780 A MX2008000780 A MX 2008000780A MX 2008000780 A MX2008000780 A MX 2008000780A MX 2008000780 A MX2008000780 A MX 2008000780A
Authority
MX
Mexico
Prior art keywords
narcotic analgesic
nmda receptors
substance
analgesic substance
therapeutic combination
Prior art date
Application number
MX2008000780A
Other languages
English (en)
Inventor
Paolo Chiesi
Gino Villetti
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MX2008000780A publication Critical patent/MX2008000780A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invencion se relaciona a un medicamento que comprende una combinacion de sustancias que bloquean tanto el canal ionico asociado a los receptores NMDA y enzimas MAO y una sustancia narcotica analgesica, preferiblemente una combinacion fija; composicion farmaceutica de la misma, y el uso de las mismas para el tratamiento contra sujetos que sufren de varios tipos de dolor y/o para inhibir el desarrollo de tolerancia, y/o dependencia fisica sobre una sustancia narcotica analgesica.
MX2008000780A 2005-07-28 2006-07-18 Combinacion terapeutica que comprende un bloqueador de receptores nmda y una sustancia narcotica analgesica. MX2008000780A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05016391 2005-07-28
PCT/EP2006/007049 WO2007017058A1 (en) 2005-07-28 2006-07-18 Therapeutic combination comprising a nmda receptors blocker and a narcotic analgesic substance

Publications (1)

Publication Number Publication Date
MX2008000780A true MX2008000780A (es) 2008-02-19

Family

ID=37114513

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2008000780A MX2008000780A (es) 2005-07-28 2006-07-18 Combinacion terapeutica que comprende un bloqueador de receptores nmda y una sustancia narcotica analgesica.

Country Status (11)

Country Link
US (1) US20080287480A1 (es)
EP (1) EP1909781A1 (es)
JP (1) JP2009502828A (es)
AU (1) AU2006278933A1 (es)
BR (1) BRPI0613281A2 (es)
CA (1) CA2616659A1 (es)
MX (1) MX2008000780A (es)
NO (1) NO20080464L (es)
NZ (1) NZ565416A (es)
WO (1) WO2007017058A1 (es)
ZA (1) ZA200800780B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CU20190114A7 (es) * 2019-12-26 2021-08-06 Centro De Investig Y Desarrollo De Medicamentos Cidem Combinación para simultáneamente incrementar la eficacia analgésica de la morfina y reducir su dependencia física

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2115792C (en) * 1993-03-05 2005-11-01 David J. Mayer Method for the treatment of pain
DK1321139T3 (da) * 2001-12-21 2007-01-02 Chiesi Farma Spa 2-indanylaminoderivater til behandling af kronisk, akut eller inflammatorisk smerte

Also Published As

Publication number Publication date
NZ565416A (en) 2011-03-31
JP2009502828A (ja) 2009-01-29
WO2007017058A1 (en) 2007-02-15
ZA200800780B (en) 2009-05-27
CA2616659A1 (en) 2007-02-15
AU2006278933A1 (en) 2007-02-15
US20080287480A1 (en) 2008-11-20
BRPI0613281A2 (pt) 2010-12-28
EP1909781A1 (en) 2008-04-16
NO20080464L (no) 2008-02-28

Similar Documents

Publication Publication Date Title
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
IL201479A (en) Use of tapentadol for the preparation of pain medication
EA201100544A1 (ru) Применение комбинации опиоидного агониста и конъюгата полимер-опиоидный антагонист для изготовления лекарственного средства для лечения и предупреждения боли
WO2008022256A3 (en) Methods and compositions for preventing or treating age-related diseases
NZ628513A (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
WO2008011487A3 (en) L-benzyl-l-hydr0xy-2, 3-diamin0-propyl amines and 3-benzyl-3-hydroxy-2-amino-propionicacid amides for chronic pain
WO2006036770A3 (en) Combination therapy for the treatment of obesity
SG152237A1 (en) Pharmaceutical combinations containing benzoxazine for treating respiratory diseases
WO2007062093A3 (en) Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
GB2431346C (en) A combination composition comprising paracetamol and ibuprofen
WO2004073615A3 (en) Deazaflavin compounds and methods of use thereof
EE200100689A (et) IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon
UA86802C2 (ru) Комбинация симетикона и бисакодила для предрасположенных к запору пациентов, которые страдают от ощущения вздутия живота
TNSN05131A1 (en) New synergistic combination comprising roflumilast and formoterol
WO2007006732A8 (en) Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)
WO2005092062A3 (en) Compounds for neurodegenerative disorders
MX2008000780A (es) Combinacion terapeutica que comprende un bloqueador de receptores nmda y una sustancia narcotica analgesica.
EA200801890A1 (ru) Средство для лечения шума в ушах
MX2007007206A (es) Uso de un agonista 5-ht6 para el tratamiento y la prevencion de trastornos neurodegenerativos.
IL197769A (en) The history of morphine, medicinal preparations containing them and their use in the preparation of pain medication
UA83017C2 (uk) Комбінація рофлуміласту та r,r-формотеролу для лікування захворювань дихальних шляхів
WO2007135123A3 (en) Mirtazapine for the treatment of neuropathic pain
MXPA05003844A (es) Compuestos con base de glucosa con afinidad para p-selectina.
IL191690A0 (en) Therapy of malignant neoplasias